Cardiac hormone replacement with BNP [nesiritide; Natrecor] in heart failure: a novel therapeutic strategy
Phase of Trial: Phase I/II
Latest Information Update: 19 Dec 2012
At a glance
- Drugs Nesiritide (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- Acronyms SubqBNP
- 31 Aug 2018 Biomarkers information updated
- 19 Dec 2012 Additional lead trial centres identified as reported by ClinicalTrials.gov.
- 25 May 2012 Actual end date changed from 1 Jul 2008 to 1 Jun 2010 as reported by ClinicalTrials.gov.